IMCD N.V. released first quarter 2026 results showing an EBITA of €129.8 million, a figure that is down 9% year-over-year but also 5% above the consensus estimate of €123.7 million from Visible Alpha.
On the top line, the specialty chemicals distributor reported an organic revenue decline of 0.8%. Regional performance diverged: Asia Pacific posted growth of 3.5%, while EMEA fell by 0.9% and the Americas were down 4.2%. These moves left overall organic revenue slightly negative versus the prior-year quarter.
Profitability metrics showed margin compression. Gross margin decreased by 116 basis points to 24.6%, which compares with the consensus estimate of 24.4%. The company’s EBITA margin narrowed by 101 basis points to 10.2%, remaining slightly ahead of the consensus estimate of 9.9%.
From a cash generation perspective, IMCD reported a 19% increase in free cash flow, which rose to €121 million. Management attributed the improvement to lower investments in working capital. The company’s leverage ratio was reported at 2.8 times EBITDA, unchanged from December 2025.
IMCD has not issued full-year guidance for 2026. At the Jefferies Mid-Cap Conference, company management described an operating environment they expect will include an avalanche of price increases, growing supply chain uncertainty, and increasing pressure on suppliers. Management said the company is well positioned to add value to both suppliers and customers in that environment.
Management also commented on competitive dynamics in semi-specialties, noting that competition from Chinese suppliers is fading with volumes being redirected to China. The company said this trend reinforces the importance of local sourcing for its supplier and customer base.
What this means
- IMCD delivered an EBITA beat versus Visible Alpha consensus despite lower year-on-year earnings.
- Asia Pacific was the only region to achieve growth in the quarter, offsetting declines in EMEA and the Americas.
- Margins contracted, but stronger free cash flow and steady leverage suggest disciplined balance sheet management.